References: Chronic Urticaria

pdfASCIA HP References: Chronic Urticaria306.2 KB

Akoglu, G., Atakan, N., Cakır, B., Kalayci, O., & Hayran, M. (2012). Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria. Arch Dermatol Res, 304(4), 257-262. https://doi.org/10.1007/s00403-011-1203-3

Anuradha, P., Maiti, R., Jyothirmai, J., Mujeebuddin, O. & Anuradha, M.  (2010). Loratadine versus levocetirizine in chronic idiopathic urticaria: a comparative study of the efficacy and safety. Indian J Pharacol, 42(1), 12-16. https://doi.org/10.4103/0253-7613.62399

Arkwright, P.D. (2009). Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol, 123(2), 510-511. https://doi.org/10.1016/j.jaci.2008.11.043

Asero, R. (2007). Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective. A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol, 32(1), 34-8. https://doi.org/10.1111/j.1365-2230.2006.02278.x

Asero, R., Tedeschi, A., & Cugno, M. (2010). Heparin and Tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. Int Arch Allergy Immunol, 152(4), 384-389. https://doi.org/10.1159/000292947

Asero, R., & Tedeschi, A.  (2010). Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. J Investig Allergol Clin Immunol, 20, 386-90. https://pubmed.ncbi.nlm.nih.gov/20945604/

Asero R, Tedeschi A, & Cugno M. (2013). Treatment of refractory chronic urticaria: current and future therapeutic options. Am J Clin Dermatol, 14(6), 481-488. https://doi.org/10.1007/s40257-013-0047-3

Augustin, M., & Ehrle S. (2009). Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients. J Eur Acad Dermatol Venereol, 23(3), 292-299. https://doi.org/10.1111/j.1468-3083.2008.03034.x

Aversano, M., Caiazzo, P., Iorio, G., Ponticiello, L., Laganá, B., & Leccese, F. (2005). Improvement of chronic idiopathic urticaria with L-thyroxine: a new TSH role in immune response? Allergy, 60(4), 89-93. https://doi.org/10.1111/j.1398-9995.2005.00723.x

Babu, K.S., Arshad, S.H., & Holgate, S.T. (2001). Omalizumab, a novel anti-IgE therapy in allergic disorders. Expert Opin Biol Ther, 1(6), 1049-1058. https://doi.org/10.1517/14712598.1.6.1049

Bagenstose, S.E., Levin, L., & Bernstein, J.A. (2004). The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol, 113(1),134-40. https://doi.org/10.1016/j.jaci.2003.10.002

Baiardini, I., Braido, F., Bindslev-Jensen, C., Bousquet, P.J., Brzoza, Z., Canonica, G.W., … Maurer, M. (2011). Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper. Allergy, 66, 840-844. https://doi.org/10.1111/j.1398-9995.2011.02580.x

Banan, P., Butler, G., & Wu, J. (2014). Retrospective chart review in a cohort of patients with urticarial dermatitis. Aust J Derm, 55(2), 137-139. https://doi.org/10.1111/ajd.12088

Baumgart, K., & Mullins, R. (2000). Use of hydroxychloroquine in refractory urticaria. J Allergy Clin Immunol, 105(1), S268-S269. http://dx.doi.org/10.1016/S0091-6749(00)91223-5

Beck, L.A., Marcotte, G.V., MacGlashan, D., Togias, A., & Saini, S. (2004). Omalizumab-induced reductions in mast cell Fc epsilon RI expression and function. J Allergy Clin Immunol, 114(3), 527-530. https://doi.org/10.1016/j.jaci.2004.06.032

Ben-Shoshan, M., Blinderman, I., & Raz, A. (2013). Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy, 68(2), 31-41. https://doi.org/10.1111/all.12068

Bernstein, J.A, Lang, D.M., Khan, D.A., Craig, T., Dreyfus, D., Hsieh, F., … Wallace, D. (2014). The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol, 133(5), 1270-1277. https://doi.org/10.1016/j.jaci.2014.02.036

Bernstein, J.A., Kavati, A., Tharp, M.D., Ortiz, B., MacDonald, K., Denhaerynck, K. & Abraham, I.L. (2018). Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systemic review of ‘real-world’ evidence. Expert Opinion on Biological Therapy, 18(4), 425-448. https://doi.org/10.1080/14712598.2018.1438406

Berth-Jones, J., Hutchinson, P.E., Wicks, A.C., & Mitchell, V.E. (1988). Chronic urticaria with angio-oedema controlled by warfarin. BMJ. 297(6660), 1382-1383. https://dx.doi.org/10.1136%2Fbmj.297.6660.1382

Bingham, C.O., Jones, P.E., Gober, L.M., Eckman, J.A., Sterba, P.M., & Saini SS. (2008). Targeted B-cell Depletion using Rituximab (Anti-CD20) in Recalcitrant Autoimmune Urticaria. J Allergy Clin Immunol, 121(2), S172.  https://doi.org/10.1016/j.jaci.2007.12.634

Bleehan, S.S., Thomas, S.E., Greaves, M.W., Newton, J., Kennedy, C.T.C., Hindley, F., … Howland, K. (1987). Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study.  Br J Dermatol, 117(1), 81-88. https://doi.org/10.1111/j.1365-2133.1987.tb04095.x

Boonpiyathad, S., Fuengthong, R., & Sangasapaviriya, A. (2013). Effect of hydroxychloroquine treatment in the patients with anti-histamine refractory chronic spontaneous urticaria, randomised controlled trial. Allergy, 68(97), 62-62. 

Boonpiyathad, T., & Sangasapaviliya, A. (2017). Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study. Eur Ann Allergy Clin Immunol, 49(5), 220-224. https://doi.org/10.23822/eurannaci.1764-1489.11

Boubouka, C.D., Charissi, C., Kouimintzis, D., Kalogeromitros, D., Stavropoulos, P.G., & Katsarou, A. (2011). Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up. Acta dermato-venereologica, 91(1), 50-4. https://doi.org/10.2340/00015555-0939

Breneman, D.L. (1996). Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother, 30(10), 1075-1079. https://doi.org/10.1177%2F106002809603001001

Broder, M.S., Raimundo, K., Antonova, E., & Chang, E. (2015). Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria. Am J Clin Dermatol, 16(4), 313-321. https://doi.org/10.1007/s40257-015-0134-8

Brown, N.A, & Carter, J.D. (2007). Urticarial Vasculitis. Curr Rheumatol, 9(4), 312-319. https://doi.org/10.1007/s11926-007-0050-x

Brüske, I., Standl, M., Weidinger, S., Klümper, C., Hoffmann, B., Schaaf, B., Herbarth I., … Heinrich, J. (2013). Epidemiology of urticaria in infants and young children in Germany – Results from the German LISAplus and GINIplus Birth Cohort Studies. Ped Allergy Immunol. 25(1). https://doi.org/10.1111/pai.12146

Bunselmeyer, B., Laubach, H.J., Schiller, M., Stanke, M., Luger, T.A., & Brehler, R. (2009). Incremental build-up food challenge - a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise food challenge in chronic urticaria. Clin Exp Allergy, 39(1)116-26. https://doi.org/10.1111/j.1365-2222.2008.03110.x

Caffarelli, C., Cuomo B, Cardinale, F., Barberi, S., Dascola, C.P., Aqostinis, F., & Bernardini, R. (2013) Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol, 93(3), 268-272. https://doi.org/10.2340/00015555-1511

Cassano, N., D’Argento, V., Filotico, R., & Vena, G. (2005). Low dose dapsone in chronic idiopathic urticaria: Preliminary results of an open study. Acta Derm Venereol, 85(3), 254–255. https://doi.org/10.1080/00015550510025560

Chakravarty, S.D., Yee, A.F., & Paget, S.A. (2011). Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol, 128(6), 1354-1355. https://doi.org/10.1016/j.jaci.2011.08.023

Chansakulporn S, Pongpreuksa S, Sangacharoenkit P, Pacharn, P., Visitsunthorn, N. Vichyanond,  Jirapongsananuruk, O. (2014). The natural history of chronic urticaria in childhood: a prospective study. J Am Acad Dermatol, 71(4), 663-668. https://doi.org/10.1016/j.jaad.2014.05.069

x

Punchama Pacharn

Search for articles by this author

Affiliations

  • Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Chua, S.L., & Gibbs, S. (2005). Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol, 153(1), 216-217. https://doi.org/10.1111/j.1365-2133.2005.06694.x

Church, M.K., Weller, C., Stock, P., & Maurer, M. (2011). Chronic spontaenous urticaria in children: Itching for insight. Paediatr Allergy Immunol, 22(1), 1-8. https://doi.org/10.1111/j.1399-3038.2010.01120.x

Clarke, J.J., Secrest, A.M., Hull, C.M., Eliason, M.J. Leiferman, K.M., Gleich, G.J. & Powell, D.L. (2016). The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review. J Am Acad Dermatol, 74(6), 1274-1276. https://doi.org/10.1016/j.jaad.2015.12.052

Curto-Baredo, l., Spertino, J., Figueras-Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., … Giménez‐Arnau, A. (2018). Omalizumab updosing allows disease control in refractory patients with chronic spontaneous urticaria. Br J Dermatol, 179(1), 210-212. https://doi.org/10.1111/bjd.16379

Di Lorenzo, G., Pacor, M.L., Mansueto, P., Pellitteri, E., Lo Bianco, C., Ditta, V., Martinelli, N., & Rini, B. (2004). Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol, 114(3), 619-625. https://doi.org/10.1016/j.jaci.2004.06.018

Diaz-Angulo, S., Lopez-Hoyos, M., Munoz Casho P, Fernandez, M., Lopez-Escobar, M., Rodriguez, F., & Gonzalez-Lopez, M.A. (2016). Prevalence of thyroid autoimmunity in Spanish patients with chronic idiopathic urticaria: a case-control study involving 343 subjects. J Eur Acad Dermatol Venereol, 30, 692-693. https://doi.org/10.1111/jdv.12979

Ditto, A. M., (2007). Hydroxychloroquine in the treatment of 12 patients with severe chronic idiopathic urticaria; a case series. J Allergy Clin Immunol, 119(1). https://doi.org/10.1016/j.jaci.2006.12.147

Doeglas, H.M., (1977). Dietary treatment of patients with chronic urticaria and intolerance to aspirin and food additives. Dermatologica, 54(5), 308-310.

Doshi, D.R., & Weinberger, M.M. (2009). Experience with cyclosporine in children with chronic idiopathic urticarial. Pediatr Dermatol, 26, 409-13. https://doi.org/10.1111/j.1525-1470.2009.00869.x

Duvall, L.A., Boackle, R.J., & King, R.G., (1986). Warfarin sodium therapy for chronic urticaria and angioedema. South Med J. 79(3), 389. https://doi.org/10.1097/00007611-198603000-00039

Eapen, A., & Kloepfer, K.M., (2018). Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria. Peadr All Immunol, 29(4), 449-450. https://doi.org/10.1111/pai.12877

Eastman, J., Wilde, N., & Jerath, M.R. (2014). Outcomes of Chronic Urticaria Patients Treated with Hydroxychloroquine. J Allergy Clin Immunol, 133(2), AB119. https://www.jacionline.org/article/S0091-6749(13)02345-2/pdf

Egeberg, A., Kofoed, K., Gislason, G.H., Vestergaard, C., & Thyssen, J.P. (2017). Cardiovascular risk is not increased in patients with chronic spontaneous urticaria: A retrospective population-based cohort study. Acta Derm Venereol, 97, 261-262. https://www.medicaljournals.se/acta/content_files/files/pdf/97/2/4800.pdf

Ehlers, I. Niggemann, B., Binder, C., & Zuberbier, T. (1998). Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy, 53(11), 1074-1077. https://doi.org/10.1111/j.1398-9995.1998.tb03817.x

Engin, B., & Ozdemir, M. (2008). Prospective randomised non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. JEADV, 22, 481–486. https://doi.org/10.1111/j.1468-3083.2007.02510.x

European Medicines Agency. Xolair summary of product characteristics. http://www. ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/ human/000606/WC500057298.pdf.

Erbagci, Z. (2002). The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled crossover clinical study.  J Allergy Clin Immunol, 110, 484-488. https://doi.org/10.1067/mai.2002.126676

Fagiolo, U., Cancian, M., Bertollo, L., Peserico, A., & Amadori, A. (1999). Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol, 103(6), 1143-1147. https://doi.org/10.1016/s0091-6749(99)70190-9

Finn, A. F., Allen, P., Kaplan, M.D., Fretwell, R.F., Qu, R & Long, J. (1999). A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol, 104(5), 1071-1078. https://doi.org/10.1016/S0091-6749(99)70091-6

Gach, J.E., Sabroe, R.A., Greaves, M.W., & Black, A.K. (2001). Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol, 145, 340-343. https://doi.org/10.1046/j.1365-2133.2001.04330.x

Gaig, P., Olona, M., Munoz Lejarazu, D., Caballero, M.T., Dominquez, F.J., Eschechipia, S., … Ferrer, M. (2004). Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol, 14(3), 214-220. https://pubmed.ncbi.nlm.nih.gov/15552715/

Garg, G., & Thami, G.P. (2007). Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.  J Dermatolog Treat, 18(1), 23-24. https://doi.org/10.1186/1939-4551-7-33

Godse, K.V. (2006). Oral monelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol, 72 (4), 312-314. https://doi.org/10.4103/0378-6323.26735

Goh, C.L., Wong, W.K., & Lim J. (1991). Cetirizine vs placebo in chronic idiopathic urticaria: a double blind randomized cross-over study. Ann Acad Med Singapore, 20(3), 328-30. https://pubmed.ncbi.nlm.nih.gov/1681778/

Goldsobel, A.B., Rohr, A.S., Siegel, S.C., Spector, S.L. Katz, R.M., Rachelefsky, G.S. …. Barr, R.J. (1986). Efficacy of doxepin in the treatment of chronic idiopathic urticarial.  J Allergy Clin Immunol. 78(5), 867-873. https://doi.org/10.1016/0091-6749(86)90232-0

Grant, J.A., Bernstein, D.I., Buckley, C.E., Chu, T., Fox, R.W., Rocklin, R.E. … Karpenter, K.M. (1998). Double-blind comparison of terfenadine, chlorpheniramine and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol, 81(3), 574-579. https://doi.org/10.1016/0091-6749(86)90232-0

Grattan, C.E., Wallington, T.B., Warin, R.P., Kennedy, C.T.C., & Bradfield, J.W. (1986). A serological mediator in chronic idiopathic urticaria- a clinical, immunological and histological evaluation. Br J Dermatol, 114(5), 583-590. https://doi.org/10.1111/j.1365-2133.1986.tb04065.x

Grattan, C.E., O’Donnell, B.F., Francis, D.M., Nimi, N., Barlow, R.J., Seed, PT., … Greaves, M.W. (2000). Randomized double blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol, 143(2), 365-372. https://doi.org/10.1046/j.1365-2133.2000.03664.x

Grattan, C.E., Dawn, G., Gibbs, S., & Francis, D.M. (2003). Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy, 33(3), 337-341. https://doi.org/10.1046/j.1365-2222.2003.01589.x

Gray, P.E., Mehr, S., Katelaris, C.H., Wainstein, B.K., Star, A., Campbell, D., … Ziegler, J.B. (2013). Salicylate elimination diets in children: is food restriction supported by the evidence? Med J Aust, 198(11), 600-602. http://dx.doi.org/10.5694/mja12.11255

Greaves, M.W. (2000). Chronic urticaria in childhood. Allergy, 55(4), 309-320. https://doi.org/10.1034/j.1398-9995.2000.00116.x

Green, J.P., & Maasyani, S. (1977). Tricyclic antidepressant drugs block histamine H2 receptors in brain. (1977). Nature, 269(5624), 163-165. https://doi.org/10.1038/269163a0

Groffik, A., Mitzel-Kaoukhov, H., Magerl, M., Maurer, M., & Staubach, P. (2011). Omalizumab-an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy, 66(2), 303-305. https://doi.org/10.1111/j.1398-9995.2010.02472.x

Guerra, L., Vinceni, C., Marchesi, E., Tosti, A., Pretto, E., Bassi, R., … De Costanza, F. (1994). Loratadine and cetirizine in the treatment of chronic urticaria. J Eur Acad Dermatol Venereol, 3(2), 148-152. https://doi.org/10.1111/j.1468-3083.1994.tb00089.x

Guida, B., De Martino, C.D., De Martino, S.D., Tritto, G., Patella, V., Trio, R., … D'Agostino L. (2000). Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr, 54(2), 155-158.  https://doi.org/10.1038/sj.ejcn.1600911

Guillén‐Aguinaga, S., Jáuregui Presa, I., Aguinaga‐Ontoso, E., Guillén‐Grima, F., & Ferrer, M. (2016). Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta‐analysis. Br J Dermatol 175(6), 1153-1165. https://doi.org/10.1111/bjd.14768

Hale,T.W., (2012). Medications and Mothers' Milk. 15th Edition.

Hall, A., & Marshall, G.D. (2013). A Retrospective review of hydroxychloroquine use in patients with chronic idiopathic urticaria (CIU). Ann Allergy Asthma Immunol, 111(5), A18-A19.

Handa, S., Dogra, S., & Kumar, B. (2004). Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat, 15(1), 55-57. https://doi.org/10.1080/09546630310013450

Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. & Weller, K. (2018). Comparison and Interpretability of the available Urticaria Activity Scores. Allergy, 73(1), 251-255. https://doi.org/10.1111/all.13271

Henz, B.M., & Zuberbier, T. (1998). Most chronic urticaria is food-dependent, and not idiopathic. Exp Dermatol, 7(4), 139-142. https://doi.org/10.1111/j.1600-0625.1998.tb00314.x

Hide, M., Francis, D.M., Grattan, C.E., Hakimi, J., Kochan, J.P. & Greaves, M.W. (1993). Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med, 328, 1599–1604. https://doi.org/10.1056/nejm199306033282204

Holgate, S., Casale, T., Wenzel, S., Bousquet, J., Deniz, Y., & Reisner, C. (2005). The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol, 115(3), 459-465. https://doi.org/10.1016/j.jaci.2004.11.053

Hrabak, T., & Calabria, C.W. (2010). Multiple treatment cycles of high-dose intravenous immunoglobulin for chronic spontaneous urticaria. Ann Allergy Asthma Immunol, 105(3), 245. https://doi.org/10.1016/j.anai.2010.05.018

Hsu, M.L., & Li, L.F. (2012). Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria. Br J Dermatol,  166(4), 747-752. https://doi.org/10.1111/j.1365-2133.2011.10733.x

Iribarren, C., Tolstykh, I.V., Miller, M.K., Sobel, E., & Eisner, M.D. (2012). Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: A prospective study of 2 matched cohorts. Am J Epidem 176(11), 1014-1024. https://doi.org/10.1093/aje/kws181

Iribarren, C., Rahmaoui, A., Long, A.A., Szefler, S.J., Bradley, M.S., Carrigan, G., … Rothman, K.J. (2017). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. J Allergy Clin Immnuol 139(5), 1489-1495. https://doi.org/10.1016/j.jaci.2016.07.038

Jaffer, A.M. (1991). Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol, 88(6), 964-965. https://doi.org/10.1016/0091-6749(91)90255-m

Jaffer, A.M., & Reid, R.T. (2002). Sulfasalazine in the treatment of chronic urticaria. J Allergy Clin Immunol, 109(1), S127. https://doi.org/10.1016/0091-6749(91)90255-m

Jariwala, S.P., Moday, H., de Asis, M.L., Fodeman, J., Hudes, G., de Vos, G., & Rosenstreich, D. (2009). The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticarial. Ann Allergy Asthma Immunol, 102(6), 475-482. https://doi.org/10.1016/s1081-1206(10)60120-2

Jauregui, I., Ortiz de Frutos, F.J., Ferrer, M., Gimenez-Arnau, A., Sastre, J., Bartra, J., … Valero, A. (2014). Assessment of severity and quality of life in chronic urticaria. Journal of Investigational Allergology and Clin Immunol 24(2), 80-86. http://www.jiaci.org/issues/vol24issue2/2.pdf

Jirapongsananuruk, O., Pongpreuksa, S., Sangacharoenkit, P., Visitsunthorn, N., & Vichyanond, P. (2010). Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients. Pediatr Allergy Immunol, 21(3), 508-514. https://doi.org/10.1111/j.1399-3038.2009.00912.x

Juhlin, L. (1981). Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol, 104(4), 369-381. https://doi.org/10.1111/j.1365-2133.1981.tb15306.x

Juhlin, L., & Arendt, C. (1988). Treatment of chronic urticaria with cetirizine dihydorchloride a non-sedating antihistaimine. Br J Dermatol, 119(1), 67-72. https://doi.org/10.1111/j.1365-2133.1988.tb07103.x

Juhlin, L. (1991). Cetirizine in the treatment of chronic urticaria. Clin Ther 13 (1), 81-86. https://pubmed.ncbi.nlm.nih.gov/1827614/

Kalivas, J., Breneman, D., Tharp, M. Bruce, S., & Bigby, M. (1990). Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86(2), 1014-1018. https://doi.org/10.1016/s0091-6749(05)80246-5

Kameyoshi, Y., Tanaka, T., Mihara, S., Takahagi, S., Niimi, N., & Hide, M. (2007). Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol, 157(4), 803-804. https://doi.org/10.1111/j.1365-2133.2007.08060.x

Kaplan, A.P. (2002). Clinical practice. Chronic urticaria and angioedema. New England Journal of Medicine, 346(3), 175-179. https://doi.org/10.1056/nejmcp011186

Kaplan, A.P. (2004). Chronic urticaria: pathogenesis and treatment. JACI 114(3), 465-474. https://doi.org/10.1016/j.jaci.2004.02.049

Kaplan, A.P., Spector, S.L., Meeves, S., Liao, Y., Verghese, S.t., & Georges, G. (2005). Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind placebo-controlled study.  Ann Allergy Asthma Immunol, 94(6), 662-669. https://doi.org/10.1016/s1081-1206(10)61325-7

Kaplan, A.P., Joseph, K., Maykut, R.J., Geba, G.P., & Zeldin, R.K. (2008). Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol, 122(3), 569-573. https://doi.org/10.1016/j.jaci.2008.07.006

Kaplan, A.P. (2012). Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res, 4(6), 326-331. https://doi.org/10.4168/aair.2012.4.6.326

Kaplan, A.P., Ferrer, M., Bernstein, J.A., Antonova, E., Trzaskoma, B., Raimundo, K., … Zazzli, J.L. (2016). Timing and duration of omalizumab response in patients with chronic spontaneous urticaria. J Allergy Clin Immunol, 137(2), 474-481. https://doi.org/10.1016/j.jaci.2015.08.023

Kapp, A., & Pichler, W.J. (2006). Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, pacebo-controlled, parallel, multicenter study. Int J Dermatol 45(4), 469-474. https://doi.org/10.1111/j.1365-4632.2005.02609.x

Kawashima, M., & Harada, M. (2001). Efficacy and safety of fexofenadine HCl in Japanese patients with chronic idiopathic urticaria. Int Arch Allergy Immunol, 124, 343-345. https://doi.org/10.1159/000053752

Kessel, A., Bamberger E., & Toubi, E. (2005). Tacrolimus in the treatment of severe chronic idiopathic urticaria: An open-label prospective study. J Am Acad Dermatol, 52(1), 145–148. https://doi.org/10.1016/j.jaad.2004.09.023

Kessel, A., & Toubi, E. (2010). Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy, 65(11), 1478-1482. https://doi.org/10.1111/j.1398-9995.2010.02419.x

Khakoo, G., Sofianou-Katsoulis, A., Perkin, M.R., & Lack, G. (2008). Clinical features and natural history of physical urticaria in children. Pediatr Allergy Immunol, 19(4), 363-366. https://doi.org/10.1111/j.1399-3038.2007.00667.x

King, W., McCargar, L., Joneja, J.M., & Barr S.I. (2000). Benefits of a Histamine-Reducing Diet for Some Patients with Chronic Urticaria and Angioedema. Can J Diet Pract Res, 61(1), 24-26.  https://pubmed.ncbi.nlm.nih.gov/11551340/

Kolkhir, P., Church, M.K., Weller, K., Metz, M., Schmetzer, O., & Maurer M. (2017). Autoimmune chronic spontaneous urticaria: What we know and what we do not know. J Allergy Clin Immunol, 139(6), 1772-1781. https://doi.org/10.1016/j.jaci.2016.08.050

Konstantinou, G.N., Papadopoulos, N.G., Tavladaki, T., Tsekoura, T., Tsilimigaki, A., & Grattan, C.E. (2011). Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences. Pediatr Allergy Immunol 22, 36-42. https://doi.org/10.1111/j.1399-3038.2010.01093.x

Konstantinou, G.N., Chioti, A.G., & Daniilidis, M. (2016). Self-reported hair loss in patients with chronic spontaneous urticaria treated with omalizumab: an under-reported, transient side effect? Eur Ann Clin Immunol, 48, 205-207. http://www.eurannallergyimm.com/cont/journals-articles/445/volume-selfreported-hair-loss-patients-with-1188allasp1.pdf

Kosnik, M., (2011). Add-on montelukast in antihistaimine-resistant chronic idiopathic urticaria. Respir Med, 105 (Suppl1), S84-S88. https://doi.org/10.1016/s0954-6111(11)70018-x

Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., … Maurer, M. (2013). Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 226(4), 371-379. https://doi.org/10.1159/000351711

Kulthanan, K., Gritiyarangsan, P., Sitakalin, C., Charuwichitratana, S., Korkij, W., Aunhacachoke, K., … Kullavanijaya P. (2001). Multicenter study of the efficacy and safety of fexofenadine 60mg twice daily in 108 Thai patients with chronic idiopathic urticaria. J Med Assoc Thai, 84(2), 153-159. https://pubmed.ncbi.nlm.nih.gov/11336071/

Kulthanan, K., Chaweekulrat, P., Komoltri, C., Hunnangkul, S., Tuchinda, P., Chularojanamontri, L., & Maurer, M. (2018). Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. J Allergy Clin Immunol Pract, 6(2), 586-599. https://doi.org/10.1016/j.jaip.2017.07.017

Lammert, J.K., & Robinson, D.M. (1996). Hydroxychloroquine (HCQ) in corticosteroid-dependent chronic urticaria (CDCU). J Allergy Clin Immunol, 97(1), 365.

Ledford, D., Broder, M.S., Antonova, E., Omachi, T.A., Chang, E., & Luskin, A. (2016) Corticosteroid-related toxicity in patients with chronic idiopathic urticarial-chronic spontaneous urticaria. Allergy Asthma Proc, 37(6), 458-465. https://doi.org/10.2500/aap.2016.37.3999

Lee, S.J., Ha, E.K., Jee, H.M., Lee, K.S., Lee, S.W., Kim, M.A., … Han, H.Y., (2017). Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Asthma Immunol Res, 9(3), 212-219. https://doi.org/10.4168/aair.2017.9.3.212

Legrain, V., Taieb , A., Sage, T., & Maleville, J. (1990). Urticaria in infants: a study of forty patients. Pediatr Dermatol, 7(2), 101-107. https://doi.org/10.1111/j.1525-1470.1990.tb00663.x

Leznoff, A., & Sussman, G.L. (1989). Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol, 84(1), 66-71. https://doi.org/10.1016/0091-6749(89)90180-2

Lieberman, P.L., Umetsu, D.T., Carrigan, G.J., & Rahmaoui, A. (2016). Anaphylactic reactions associated with omalizumab administration: Analysis of a case control study. J Allergy Clin Immunol 138(3), 913-915. https://doi.org/10.1016/j.jaci.2016.03.030

Lindsay, K., Goulding, J., Solomon, M., & Broom, B. (2015). Treating chronic spontaneous urticaria using a brief ‘whole person’ treatment approach: a proof-of-concept study. Clin Transl Allergy, 5, 40. https://ctajournal.biomedcentral.com/track/pdf/10.1186/s13601-015-0082-7.pdf

Liu, T.H., Lin, Y.R., Yang, K.C., Tsai, Y.G., Fu, Y.C., Wu, T.K., & Wu, H.P. (2010). Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol, 21(7), 1043-1051. https://doi.org/10.1111/j.1399-3038.2010.01070.x

Long, A., Rahmaoui, A., Rothman, K.J., Guinan, E., Eisner, M., Bradley, M.S., …  Szefler, S.J. (2014). Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol, 134(3), 560-567. https://doi.org/10.1016/j.jaci.2014.02.007

Lynde, C., Sussman, G., Hébert, J., Gulliver, W., Yang, W.H., Chambenoit, O., … Rihakova, L. (2017).  Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Chronic Spontaneous Urticaria Following Return of Symptoms: Primary Results of the OPTIMA Study EADV. Poster abstract presented at the Clinical Dermatology Conference.

Magen, E., & Mishal, J. (2012). The effect of L-thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis. Int J Dermatol, 51(1), 94-97. https://doi.org/10.1111/j.1365-4632.2011.05172.x

Magerl, M., Pisarevskaja, D., Scheufele, R., Zuberbier, T., & Maurer, M. (2010). Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy, 65(1), 78-83. https://doi.org/10.1111/j.1398-9995.2009.02130.x

Malanin, G., & Kalimo, K. (1989). Results of skin testing with food additives and the effect of an elimination diet in chronic and recurrent urticaria and recurrent angioedema. Clin Exp Allergy, 19(5), 539-543. https://doi.org/10.1111/j.1365-2222.1989.tb02430.x

Mallipeddi, R., & Grattan, C.E. (2007). Lack of response of severe steroid-dependent chronic urticaria to rituximab. Clin Exp Dermatol, 32(3), 333-334. https://doi.org/10.1111/j.1365-2230.2007.02365.x

McGirt, L.Y., Vasagar, K., Gober, L.M., Saini, S.S., & Beck, L.A. (2006). Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol, 142(10),1337-1342. https://doi.org/10.1001/archderm.142.10.1337

Metz, M., Ohanyan, T., Church, M.K., & Maurer, M. (2014). Retreatment with omalizumab results in rapid remission in chronic spontaneous urticaria. JAMA Dermatol, 150, 288-290. https://doi.org/10.1001/jamadermatol.2013.8705

Metz, M., Ohanyan, T., Church, M.K., & Maurer, M. (2014). Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. J Dermatol Sci,  73(1), 57-62. https://doi.org/10.1016/j.jdermsci.2013.08.011

Mitzel-Kaoukhov, H., Staubach, P., & Muller-Brenne, T. (2010). Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. Ann Allergy, Asthma & Immunol 104, 253-258. https://doi.org/10.1016/j.anai.2009.12.007

Mlynek, A., Zalewska-Janowska, A., Martus, P., Staubach, P., Zuberbier, T., Maurer, M. (2008). How to assess disease activity in patients with chronic urticaria? Allergy (6), 777-780. http://dx.doi.org/10.1111/j.1398-9995.2008.01726.x

Monroe, E.W., Cohen, S.H., Kalbfleisch, J., & Schulz, C.I. (1981). Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol, 117(7), 404-407. doi:10.1001/archderm.1981.01650070032018

Monroe, E.W., Fox, R.W., Green, A.W., Izuno, C.G.T., Bernstein, D.I., Pleskow, W.W., Wills, I., & Brigante, J.R. (1988). Efficacy and safety of loratadine (10mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol, 19(1), 138-139. https://doi.org/10.1016/s0190-9622(88)80230-5

Mathias, S.D., Crosby, R.D., Zazzali, J.L., Maurer, M., & Saini, S.S. (2012). Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol, 108, 20-24. https://doi.org/10.1016/j.anai.2011.09.008

Maurer, M., Altrichter, S., Bieber, T., (2011). Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol, 128, 202e205–209e205. https://doi.org/10.1016/j.jaci.2011.04.038

Maurer, M., Rosen, K., Hsieh, H.J., Saini, S., Grattan, C., Gimenez-Arnau, A., … Casale. T., (2013). Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med; 368(10), 924-935. https://doi.org/10.1056/nejmoa1215372

Maurer, M., Church, M.K., & Weller, K. (2017). Chronic urticaria in children, still itching for insight. JAMA Derm, 153(12), 1221-1222. http://doi:10.1001/jamadermatol.2017.3183

Monroe, E.W. (1992). Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther, 14(1), 17-21. https://pubmed.ncbi.nlm.nih.gov/1445478/

Monroe, E.W. (1992). Relative efficacy and safety of loratadine, hydroxyzine and placebo in chronic idiopathic urticaria. Arzneimittelforschung, 42(9), 1119-1121. https://pubmed.ncbi.nlm.nih.gov/1349509/

Monroe, E., Finn, A., Patel, P., Guerrero, R., Ratner, P., & Bernstein, D. (2003). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol, 48(4), 535-541. https://doi.org/10.1067/mjd.2003.143

Morgan, M., Cooke, A., Rogers, L., Adams-Huet, B., & Khan, D.A. (2014). Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract, 2(5), 601-606. https://doi.org/10.1016/j.jaip.2014.06.004

Mortureux, P., Leaute-Labreze, C., Legrain-Lifermann, V., Lamireau, T., Sarlangue, J., & Taieb, A. (1998). Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol, 134(3), 319-23. https://doi.org/10.1001/archderm.134.3.319

Namazy, J., Cabana, M.D., Scheuerle, A.E., Thorp, J.M., Chen, H., Carrigan, G., Wang, Y., Veith, J., & Andrews, E.B. (2015). The Xolair pregnancy registry (EXPECT): The safety of omalizumab use during pregnancy. J Allergy Clin Immunol, 135(2), 407-412. https://www.jacionline.org/article/S0091-6749(14)01198-1/pdf

Nelson, H.S., Raynolds, R., & Mason J.  (2000). Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol, 84(5), 517-522. https://doi.org/10.1016/s1081-1206(10)62515-x

Netchiporouk, E., Sasseville, D., Moreau, L., Habel, Y., Rahme, E., & Ben-Shoshan, M. (2017). Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Derm, 153(12), 1236-1242. https://doi.org/10.1001/jamadermatol.2017.3182

Nettis, E., Dambra, P., D’Oronzio, L., Loria, M.P., Ferrannini, A., & Tursi, A. (2001). Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.  Arch Dermatol, 137(1) 99-100.

Nettis, E., Pannofino, A., Cavallo, E., Ferrannini, A., & Tursi, A. (2003).  Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria.  J Allergy Clin Immunol, 112(1), 212-213. https://doi.org/10.1067/mai.2003.1559

Nettis, E., Colanardi, M.C., Paradiso, M.T. & Ferrannini, A.  (2004). Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy, 34(9), 1401-1407.  https://doi.org/10.1111/j.1365-2222.2004.02019.x

Nettis, E., Clolanardi, M.C., Barra, L., Ferrannini, A., Vacca, A., & Tursi, A. (2006). Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol, 154(3), 533-538. https://doi.org/10.1111/j.1365-2133.2005.07049.x

Noshela Ghazanfar, M., & Thomsen, S.F. (2017). Transient hair loss in patients with chronic spontaneous urticaria treated with omalizumab. Eur Ann Allergy Clin Immunol, 49(6), 284-285. https://doi.org/10.23822/eurannaci.1764-1489.08

O'Donnell, B.F., Barr, R.M., Black, A.K., Francis, D.M., Kermani, F., Niimi, N., … Greaves, M.W. (1998). Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 138(1), 101-106. Intravenous immunoglobulin in autoimmune chronic urticaria

Ohanyan, T., Schoepke, N., Bolukbasi, B., Metz, M., Hawro, T., Zuberbier, T., … Weller, K. (2017). Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol, 140(6), 1710-1713. https://doi.org/10.1016/j.jaci.2017.04.050

Orden, R.A., Timble, H., & Saini, S.S. (2014). Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 112(1), 64-70. https://doi.org/10.1016/j.anai.2013.09.028

Ortonne, J.P., Grob, J.J., Auquier, P., & Dreyfus, I. (2007). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol, 8(1), 37-42. https://doi.org/10.1067/mjd.2003.143

Pacor, M.L., Di Lorenzo, G., & Corrocher, R.  (2001). Efficacy of leukotriene receptor antagonist in chronic urticaria.  A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.  Clin Exp Allergy, 31(10),1607-1614. https://doi.org/10.1046/j.1365-2222.2001.01189.x

Parslew, R., Pryce D, Ashworth J, & Friedmann PS. (2000). Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy, 30(8), 1161-1165. https://doi.org/10.1046/j.1365-2222.2000.00857.x

Paul, E., & Bodeker, R.H. (1986). Treatment of chronic urticaria with terfenadine and ranitidine.  A randomized double-blind study in 45 patients. Eur J Clin Pharmacol, 31(3), 277-280. https://doi.org/10.1007/bf00981123

Perez, A., Woods, A., & Grattan, C.E. (2010). Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol, 162(1), 191-194. https://doi.org/10.1111/j.1365-2133.2009.09538.x

Pitt, T., Warrington, R., & Kalicinsky, C. (2010). Adjunctive treatment of chronic idiopathic urticaria and angioedema with sulfasalazine. Allergy Asthma Clin Immunol, 6(1), 25. https://aacijournal.biomedcentral.com/track/pdf/10.1186/1710-1492-6-S1-P25.pdf

Pongonis, R.M., & Fahrenholz, J.M. (2012). Efficacy of Hydroxychloroquine in the Treatment of 19 Patients with Antihistamine-refractory Chronic Urticaria. J Allergy Clin Immunol, 129(2), AB224. https://doi.org/10.1016/j.jaci.2011.12.122

Potter, P.C., Kapp, A., Maurer, M., Guillet, G., Jian, A.M., Hauptmann, P., & Finlay, A.Y. (2009). Comparison of the efficacy of levocetirizine 5mg and desloratadine 5mg in chronic idiopathic urticaria patients. Allergy, 64(4), 596-604. https://doi.org/10.1111/j.1398-9995.2008.01893.x

Powell, R.J., Du Toit, G.L., Siddique, N., Leech, S.C., Dixon, T.A., Clark, A.T., … Huber, P.A. (2007). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy, 37(5), 631-650. https://doi.org/10.1111/cea.12494

Puccetti, A., Bason, C., Simeoni, S., Millo, E., Tinazzi, E., Beri, R., …  Lundari C. (2005). In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy, 35(12), 1599-1607. https://doi.org/10.1111/j.1365-2222.2005.02380.x

Raghavendran, R.R., Humphreys, F., & Kaur, M.R. (2014). Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to cyclosporin. Clin Exp Dermatol, 39(1), 68-69. https://doi.org/10.1111/ced.12156

Rajan, J., Simon, R., & Bosso, J. (2014). Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. J Allergy Clin Immunol Pract, 2(2), 168-171. https://doi.org/10.1016/j.jaip.2013.10.002

Reese, I., Zuberbier, T., Bunselmeyer, B., Erdmann, S., Henzgen, M., Fuchs, T., … Werfel T. J. (2009). Diagnostic approach for suspected pseudoallergic reaction to food ingredients. Dtsch Dermatol Ges, 7(1), 70-77. https://doi.org/10.1111/j.1610-0387.2008.06894.x

Reeves, G., Boyle, M., Bonfield, J., Dobson, P., & Loewenthal, M. (2004). Impact of hydroxycholoroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Internal Medicine Journal, 34(4),182-186. https://doi.org/10.1111/j.1444-0903.2004.00532.x

Reider, N., & Egger, C. (2009). Infliximab in the treatment of refractory chronic urticaria. J Am Acad Dermatol, 60(3), AB39. https://doi.org/10.1016/j.jaad.2008.11.193

Reimers, A., Pichler, C., Helbling, A., Pichler, W.J., & Yawalkar, N. (2002). Zafirlukast has no beneficial effects in the treatment of chronic urticaria.  Clin Exp Allergy, 32(12), 1763-1768 https://doi.org/10.1046/j.1365-2222.2002.01536.x

Richelson, E. (1979). Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc, 54, 669. https://pubmed.ncbi.nlm.nih.gov/39202/

Ring, J., Hein, R., Gauger, A., Bronsky, E., & Miller, B. (2001). Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind placebo-controlled study. Int J Dermatol, 40(1), 72-76. https://doi.org/10.1046/j.1365-4362.2001.00186.x

Rorie, A., Goldner, W.S., Lyden, E., & Poole, J.A. (2014). Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study. Ann Allergy Asthma Immunol, 112(4), 376-382. https://doi.org/10.1016/j.anai.2014.01.010

Rudzki, E., Czubalski, K., & Grzywa, Z. (1980). Detection of urticaria with food additives intolerance by means of diet. Dermatologica, 161(1), 57-62. https://doi.org/10.1159/000250331

Rumbyrt, J.S., Katz, J.L., & Schocket AL. (1995). Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. 96(6 Pt 1), 901-905. https://doi.org/10.1016/S0091-6749(95)70226-1

Sabroe, R.A., & Greaves, M.W. (2006). Chronic idiopathic urticaria with functional autoantibodies: 12 years on. Br J Dermatol. 154(5), 813-819. https://doi.org/10.1111/j.1365-2133.2006.07183.x

Sackesen, C., Sekerel, B.E., Orhan, F., Kocabas, C.N., Tuncer, A., & Adalioglu, G. (2004). The etiology of different forms of urticaria in childhood. Pediatr Dermatol, 21(2), 102-108. https://doi.org/10.1111/j.0736-8046.2004.21202.x

Sagi, L., Solomon, M., Baum, S., Lyakhovitsky, A., Trau, H., & Barzilai, A. (2011). Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria. Acta Dermato Venereol, 91(3), 303-306. https://doi.org/10.2340/00015555-1080

Sahiner, U.M., Civelek, E., Tuncer, A., Yavuz, S.T., Karabulut, E., Sackesen, C., & Sekerel, B.E. (2011). Chronic urticaria: etiology and natural course in children. Int Arch Allergy Immunol, 156(2), 224-230. https://doi.org/10.1159/000322349

Saini, S.S., & MacGlashan, D. (2002). How IgE upregulates the allergic response. Curr Opin Immunol, 14(6), 694-697. https://doi.org/10.1016/s0952-7915(02)00404-1

Saini, S. S., Rosen, K.E., Hsieh, H.J., Wong, D.A., Conner, E., Kaplan, A., Spector, S., & Maurer, M. (2011). A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol, 128(3), 567-573. https://doi.org/10.1016/j.jaci.2011.06.010

Saini, S.S., Bindslev-Jensen, C., Maurer, M., Grob, J.J., Bulbul Baskan, E., Bradley, M.S., … Rosen, K. (2015). Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol,135(1), 67-75. https://dx.doi.org/10.1038%2Fjid.2014.306

Samarasinghe, V., & Marsland, A.M. (2012). Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria. Clin Exp Dermatol, 37(7), 741-743. https://doi.org/10.1111/j.1365-2230.2011.04281.x

Sand, F.L., & Thomsen, S.F. (2013). TNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 Patients. J Allergy (Cairo), 130905. https://dx.doi.org/10.1155%2F2013%2F130905

Shahar, E., Bergman, R., Guttman-Yassky, E., & Pollack, S. (2006). Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. International Journal of Dermatology, 45, 1224-1227. https://doi.org/10.1111/j.1365-4632.2006.02655.x

Shamsi, Z., & Hindmarch, I. (2000). Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.  Human Psychopharmacol, 15(s1), s3-s30.  https://doi.org/10.1002/1099-1077(200010)15:1+%3C::aid-hup247%3E3.0.co;2-s

Shamsi, Z., & Hindmarch, I. (2008). Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.  Human Psychopharmacol, 23(7), 555-570. https://doi.org/10.1002/hup.962

Sharma, V.K., Singh, S., Ramam, M., Kumawat, M., & Kumar, R. (2014). A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Indian J Dermatol Venereol Leprol, 80(2), 122-128. https://doi.org/10.4103/0378-6323.129382

Sharpe, G.R., & Shuster, R. (1993). In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol, 129(5), 575-579. https://doi.org/10.1111/j.1365-2133.1993.tb00487.x

Shin, M., & Lee, S., (2017). Prevalence and causes of childhood urticaria. Allergy, Asthma & Immunology Research, 9(3), 189-190. https://doi.org/10.4168/aair.2017.9.3.212

Siebenhaar, F., Degener. F., Zuberbier. T., MArtus, P. & Maurer, M. (2009). High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled crossover study. J Allergy Clin Immunol, 123(3), 672-679. https://doi.org/10.1016/j.jaci.2008.12.008

Simons, F.E. (2001). Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol, 107(4), 703-706. https://doi.org/10.1067/mai.2001.113866

Spector, S.L., Shikiar, R., Harding, G., Meeves, S., & Leahy, M.J. (2007). The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. Cutis, 79(2), 157-162. https://europepmc.org/article/med/17388220

Staevska, M., Popov, T.A. Kralimarkova, T., Lazatova, C., Kraeva, S., Popova, D., … Church, M.K. (2010). The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.  J Allergy Clin Immunol, 125(3), 676-682. https://doi.org/10.1016/j.jaci.2009.11.047

Staevska, M., Gugutkova, M., Lazarova, C. Kralimarkova, T., Dimitrov, V., Zuberbier, T., Church, M.K. & Popov, T.A. (2014). Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.  Br J Dermatol, 171(1), 148-154.  https://doi.org/10.1111/bjd.12846

Staubach, P., Dechene, M., Metz, M., Magerl, M., Siebenhaar, F., Weller, K., … Maurer, M. (2011). High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol, 91(5), 557-561. https://doi.org/10.2340/00015555-1109

Staubach, P., Metz, M., Chapman-Rothe, N., Sieder, C., Brautigam, M., Canvin, J., & Maurer, M. (2016). H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. Allergy, 71(8), 1134-1144. https://doi.org/10.1111/all.12870

Sussman, G., Hébert, J., Barron, C., Bian, J., Caron-Guay, R.M., Laflamme, S., & Stern, S. (2014). Real-life experiences with omalizumab for the treatment of chronic urticaria. Ann Allergy Asthma Immunol, 112(2), 170-174. https://doi.org/10.1016/j.anai.2013.12.005

Tal, Y., Toker, O., Agmon-Levin, N., & Shalit, M. (2014). Azathioprine as a therapeutic alternative for refractory chronic urticaria. Int J Dermatol, 54(3), 367-369. http://dx.doi.org/10.1111/ijd.12536

Tedeschi, A. (2009). Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. Europ Ann Allergy Clin Immunol, 41(6), 187-189. http://www.eurannallergyimm.com/cont/journals-articles/175/volume-paradoxical-exacerbation-chronic-urticaria-hantihistamines-470allasp1.pdf

Thompson, A.K., Finn, A.F., & Schoenwetter, W.F. (2000). Effect of 60mg twice-daily fexofenadine HCl on quality of life work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.  J Am Acad Dermatol 43(1 Pt 1), 24-30. https://doi.org/10.1067/mjd.2000.104680

Tondury, B., Muehleisen, B., Ballmer-Weber, B.K., Hofbauer, G., Schmid-Grendelmeier, P., French, L., & Buchi, S. (2011). The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria. J Investig Allergol Clin Immunol, 21(2), 93-100. http://dx.doi.org/10.5167/uzh-48861

Toubi E, Kessel A, Avshovich N, Bamber E, Sabo E, Nusem D, Panasoff J. (2004). Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy, 59, 869-873. https://doi.org/10.1111/j.1398-9995.2004.00473.x

Vadasz, Z., Tal, Y., Rotem, M., Shichter-Confino, V., Mahlab-Guri, K. Graif, Y., … Sthoeger, Z. (2017). Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients. J Allergy Clin Immunol Pract, 5(6), 1743-1745. https://doi.org/10.1016/j.jaip.2017.08.035

Van den Elzen, M., van Os-Medendorp, H., van den Brink, I., van den Hurk, K., Kouznetsova, O.I., … Knulst, A.C. (2017). Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria. Clinical and Translational Allergy, 7(4). https://dx.doi.org/10.1186%2Fs13601-017-0141-3

Varghese, R., Rajappa, M., Chandrashekar, L., Kattimani, S., Archana, M., Munisamy, M., Revathy, G., & Thappa D. M. (2016) Association among stress, hypocortisolism, systemic inflammation, and disease severity in chronic urticaria. Ann Allergy Asthma Immunol. 116(4), 344-348.  https://doi.org/10.1016/j.anai.2016.01.016

Vena, G., Cassano, N., Colombo, D., Peruzzi, E., & Pigatto, P. (2006). Cyclosporine in chronic idiopathic urticaria: a double-blind, randomised, placebo-controlled trial. J Am Acad Dermatol 55, 705–709. https://doi.org/10.1016/j.jaad.2006.04.078

Verschave, A., Stevens, E., & Degreef, H. (1983). Pseudo-allergen-free diet in chronic urticaria. Dermatologica, 167(5), 256-259. https://doi.org/10.1159/000249792

Wagner, N., Dirk, D., Peveling-Oberhag, A., Reese, I., Rady-Pizarro, U., Mitzel, H., & Staubach, P. (2017). A Popular myth - low-histamine diet improves chronic spontaneous urticaria - fact or fiction? J Eur Acad Dermatol Venereol, 31(4), 650-655. https://doi.org/10.1111/jdv.13966

Wan, K.S. (2009). Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.  J Dermatolog Treat, 20, 194-197. https://doi.org/10.1080/09546630802607495

Wan, K.S., & Chang, (2014). Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria. J Dermatolog Treat, 25(6), 459-461. https://doi.org/10.3109/09546634.2013.849791

Weller, K.G., Magerl, M., Tohme, N., Martus, P., Krause, K., Metz, M., Staubach, P., & Maurer M. (2013). Development, Validation and Initial Results of the Angioedema Activity Score. Allergy, 68(9),1185-1192. https://doi.org/10.1111/all.12209

Weller, K., Groffik, A., Church, M.K., Hawro, T., Krause, K., Metz, M., … Maurer, M. (2014). Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy and Clin Immunol, 133(5), 1365-1372. https://doi.org/10.1016/j.jaci.2013.12.1076

Wetter, D.A., Davis, M.D., Yiannias, J.A., Gibson, L.E., Dahl, M.V., el-Azhary, R.A., … Pittelkow, M.R. (2005). Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clinic Proceedings 80, 41-47. https://doi.org/10.4065/80.1.41

Wilson, L.H., Eliason, M.J., Leiferman, K.M., Hull, C.M., & Powell, D.L. (2011). Treatment of refractory chronic urticaria with tumor necrosis factor alfa inhibitors. J Am Acad Dermatol. 64(6), 1221-1222. https://doi.org/10.1016/j.jaad.2009.10.043

Zimmerman, A.B., Berger, E.M., Elmariah, S.B., & Soter, N.A. (2012). The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. Journal of the American Academy of Dermatology, 66, 767-770. https://doi.org/10.1016/j.jaad.2011.06.004

Zitelli, K.B., & Cordoro, K.M. (2011). Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol, 28(6), 629-639.  https://doi.org/10.1111/j.1525-1470.2011.01518.x

Zuberbier, T., Chantraine-Hess, S., Hartmann, K., & Czarnetzki, B.M. (1995). Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol. 75(6), 484-487. https://doi.org/10.2340/0001555575484487

Zuberbier, T., Munzberger, C., Haustein, U., Trippas, E., Burtin, B., Mariz, S.D. & Henz, B.M. (1996). Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology, 193(4), 324-327. https://doi.org/10.1159/000246281

Zuberbier, T. (2001). The role of allergens and pseudoallergens in urticaria. J Investig Dermatol Symp Proc, 6(2), 132-134. https://doi.org/10.1046/j.0022-202x.2001.00024.x

Zuberbier, T., Asero, R., Bindslev-Jensen, G., Canonica, G., Church, M.k., Gimenez0Arnau, A., … Maurer, M. (2009). The EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy, 64(10), 1417-1426. https://doi.org/10.1111/j.1398-9995.2009.02179.x

Zuberbier, T., Balke, M., Worm, M., Edenharter, G., & Maurer, M. (2010). Epidemiology of Urticaria; a representive cross-sectional population survey. Clin Exp Dermatol, 35(8), 869-783.  https://doi.org/10.1111/j.1365-2230.2010.03840.x

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A.H., Baker, D., Ballmer-Weber, B., … Maurer, M. (2018). The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update. Allergy 73(7), 1393-1414. https://doi.org/10.1111/all.13397

© ASCIA 2021

ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand.

ASCIA resources are based on published literature and expert review, however, they are not intended to replace medical advice. The content of ASCIA resources is not influenced by any commercial organisations.

For more information go to www.allergy.org.au

To donate to immunology/allergy research go to www.allergyimmunology.org.au

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.